Beckerman will represent Elixinol’s position in hemp industry’s dynamic U.S. regulatory and advocacy environment
DENVER , Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elixinol, a wholly owned subsidiary of Elixinol Global (EXL) (ASX: EXL; OTC: ELLXF), announces Joy Beckerman’s appointment to Elixinol’s team starting January 1, 2019.
Few individuals can compare to Beckerman when it comes to dedication to advocacy for the hemp plant. She has been pioneering the path for hemp legalization and cultivation for most of her life and will be a valued addition to the Elixinol team.
In Beckerman’s role as Regulatory Officer and Industry Liaison, she will advise Elixinol’s executive team on the industry’s changes and ensure Elixinol’s practices continue to meet or exceed the requirements of hemp’s dynamic regulatory framework following the 2018 Farm Bill which federally legalized hemp. In addition, Beckerman will represent Elixinol in national and regional cannabis and hemp industry alliances and memberships, including the Hemp Industries Association, the National Hemp Association, Vote Hemp, and sharing Elixinol’s representation with Gabriel Ettenson at the U.S. Hemp Roundtable.
“We’re proud to announce Joy is joining Elixinol. Joy’s contributions to the U.S. hemp industry, and her decades of advocacy, policy, and regulatory insight, are significant for their longevity, knowledge, and passion,” said Gabriel Ettenson, President, Elixinol.
“We know Joy will be a valuable team member as Elixinol continues to lead the industry with the highest of standards,” he continued.
Beckerman’s extensive industry influence and experience has redefined hemp industry standards and advocacy and will ensure that Elixinol remains an industry leader and leads the hemp industry’s development in best practices and regulatory adherence.
“I appreciate Elixinol’s ‘Do Good, Be Good,’ philosophy which is actively demonstrated through their seed-to-sale quality standards and widely acknowledged support for the important work undertaken by non-profits,” said Beckerman.
“Elixinol has already been a leading voice on regulatory, legal, and manufacturing standards and I look forward to the continued advancement of U.S. hemp and Elixinol’s advocacy and industry leadership,” she continued.
In addition to serving as President of the Hemp Industries Association, a non-profit trade association founded in 1994 that represents over 1,200 hemp farmers and business members in the U.S., Beckerman is also Vice President of the U.S. Hemp Authority, which created the first certification seal program for hemp industry Current Good Manufacturing Practices and Good Agricultural Practices. She also serves as National Board Member for NORML (National Organization for the Reform of Marijuana Laws). Most recently, Beckerman has served multiple clients as Principal of Hemp Ace International, a New York-based consulting, legal support, and expert witness firm serving the global hemp community. Beckerman’s extensive background in compliance and complex civil litigation support includes high profile corporate cases and multiple multi-million-dollar civil lawsuits.
As a hemp industry leader and internationally renowned educator and public speaker, Beckerman has received accolades from industry organizations for her contributions, including earning her the 2014 “National Hemp Activist of the Year” award from the Hemp Industries Association.
Beckerman will report to Elixinol President Gabriel Ettenson. She will remain on the Boards of leading industry institutions and continue to speak around the globe on hemp’s future and the U.S. regulatory environment.
Colorado-based Elixinol, co-founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and extracting premium-quality hemp, Elixinol is one of the few CBD hemp extract brands with complete seed-to-sale control over its products. Elixinol also conducts rigorous third-party laboratory testing and quality control. Elixinol distributes hemp-derived CBD products in 40 countries globally including North and South America, throughout Europe, Asia, and the Pacific Region under its own label as well as bulk CBD and wholesale CBD. Elixinol’s parent company EXL (elixinolglobal.com) is publicly traded on the Australian Securities Exchange and on the U.S. OTC (ASX:EXL, OTCQX: ELLXF). More information available at Elixinol.com.